DK0455769T3 - Use of 7-OH-1,2-benzopyrone in the manufacture of a medicament for the treatment of human magline tumors - Google Patents

Use of 7-OH-1,2-benzopyrone in the manufacture of a medicament for the treatment of human magline tumors

Info

Publication number
DK0455769T3
DK0455769T3 DK90917032.6T DK90917032T DK0455769T3 DK 0455769 T3 DK0455769 T3 DK 0455769T3 DK 90917032 T DK90917032 T DK 90917032T DK 0455769 T3 DK0455769 T3 DK 0455769T3
Authority
DK
Denmark
Prior art keywords
benzopyrone
human
magline
tumors
medicament
Prior art date
Application number
DK90917032.6T
Other languages
Danish (da)
Inventor
R Douglas Thornes
Helga Stolze
Ernest Marshall
Kurt Zaenker
Original Assignee
Schaper & Bruemmer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper & Bruemmer Gmbh filed Critical Schaper & Bruemmer Gmbh
Application granted granted Critical
Publication of DK0455769T3 publication Critical patent/DK0455769T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns the use of 1,2-benzopyrone derivatives, in particular umbelliferone, esculine, esculetine and scopoletine, to treat malignant tumours in humans. The derivatives claimed are suitable for both preventive and therapeutic treatment, and they exhibit in particular a growth-inhibiting action against brain-tumour cells, as well as against cells from human kidney, prostate-gland, skin and lung carcinomas.
DK90917032.6T 1989-11-24 1990-11-23 Use of 7-OH-1,2-benzopyrone in the manufacture of a medicament for the treatment of human magline tumors DK0455769T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3938902A DE3938902C1 (en) 1989-11-24 1989-11-24

Publications (1)

Publication Number Publication Date
DK0455769T3 true DK0455769T3 (en) 1996-02-05

Family

ID=6394102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917032.6T DK0455769T3 (en) 1989-11-24 1990-11-23 Use of 7-OH-1,2-benzopyrone in the manufacture of a medicament for the treatment of human magline tumors

Country Status (11)

Country Link
EP (1) EP0455769B1 (en)
JP (1) JP3053645B2 (en)
KR (1) KR0177821B1 (en)
AT (1) ATE128354T1 (en)
AU (1) AU6739690A (en)
BR (1) BR9007080A (en)
CA (1) CA2045593C (en)
DE (2) DE3938902C1 (en)
DK (1) DK0455769T3 (en)
FI (1) FI913531A0 (en)
WO (1) WO1991007959A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822379B1 (en) * 2001-03-20 2007-06-15 Sederma Sa COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING UMBELLIFERONE
US7148252B2 (en) * 2001-10-03 2006-12-12 Signal Pharmaceuticals, Llc Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096887A (en) * 1984-03-01 1992-03-17 Lamorna Investments Proprietary Limited Treatment of high protein oedemas

Also Published As

Publication number Publication date
WO1991007959A1 (en) 1991-06-13
AU6739690A (en) 1991-06-26
EP0455769A1 (en) 1991-11-13
KR0177821B1 (en) 1999-03-20
CA2045593A1 (en) 1991-05-25
KR920700636A (en) 1992-08-10
FI913531A0 (en) 1991-07-23
BR9007080A (en) 1991-12-24
EP0455769B1 (en) 1995-09-27
JP3053645B2 (en) 2000-06-19
ATE128354T1 (en) 1995-10-15
JPH04505020A (en) 1992-09-03
DE3938902C1 (en) 1991-05-08
DE59009724D1 (en) 1995-11-02
CA2045593C (en) 2000-09-05

Similar Documents

Publication Publication Date Title
CY1105818T1 (en) USES OF ET743 IN THE THERAPEUTIC TREATMENT OF CANCER
IS4073A (en) New multifunctional drug for increased resistance
EA200000723A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
TR200201442T2 (en) Preparation and use of radium-223 for calcified target tissues for pain relief, bone cancer therapy, and keeping bone surface healthy.
PT933995E (en) METHOD FOR TREATMENT OF ENDOTHELIAL LESION
IT8419266A1 (en) DEVICE TO GENERATE HEAT IN TISSUES "OF THE HUMAN BODY AND PROCEDURE OF HEAT CENERATION, PARTICULARLY FOR THE TREATMENT OF CANCER
MY121548A (en) Compounds and methods for the treatment of cancer
DK209088D0 (en) MEDICINAL PREPARATIONS, THEIR MANUFACTURING AND USE
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
ATE197670T1 (en) PARENTERAL BUSULFAN FOR THE TREATMENT OF MALIGNANT DISEASES
BR0115162A (en) Effective antitumor treatments
EP0511306A4 (en) Tumor killing effects of enterotoxins and related compounds
AU1206292A (en) Therapeutic agents for the treatment of multidrug resistance to cancers
ATE406897T1 (en) COMBINATION OF ET-743 WITH 5-FLUOROURACIL PRO-DRUGS FOR THE TREATMENT OF CANCER
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
ATE192923T1 (en) USE OF BOSWELLIC ACID TO TREAT BRAIN TUMORS
DK0455769T3 (en) Use of 7-OH-1,2-benzopyrone in the manufacture of a medicament for the treatment of human magline tumors
WO2023164455A3 (en) Compositions and methods to modulate the immune system
ATE345805T1 (en) CALCIUM TRIFLUOROCETATE WITH CYTOTOXIC EFFECT
ES2058161T3 (en) ACTIVE PRODUCT FOR THE FIGHT AGAINST TUMORS.
DE3373907D1 (en) N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor
SE9404405L (en) Radiation restriction device
ATE89727T1 (en) OPTICALLY PURE DEXNIGULDIPINE AND ITS DERIVATIVES FOR THE TREATMENT OF TUMOR DISEASES.
ES2106858T3 (en) NEW DERIVATIVES OF CYTARABINE, ITS PREPARATION PROCEDURE AND ITS USE AGAINST CANCER DISEASES.
UA28928A (en) Method of purulent-inflammatory desease of soft tissues